Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
56
CNK Quote, Financials, Valuation and Earnings
Last price:
$29.87
Seasonality move
:
-1.27%
Day range:
$29.35 - $29.92
52-week range:
$16.32 - $36.28
Dividend yield:
0.27%
P/E ratio:
14.73x
P/S ratio:
1.53x
P/B ratio:
6.15x
Volume:
3.5M
Avg. volume:
3.8M
1-year change:
74.5%
Market cap:
$3.7B
Revenue:
$3B
EPS (TTM):
$2.03
Analysts' Opinion
-
Consensus RatingCinemark Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $33.33, Cinemark Holdings has an estimated upside of 11.45% from its current price of $29.91.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 26.45% downside risk from its current price of $29.91.
Fair Value
-
According to the consensus of 5 analysts, Cinemark Holdings has 11.45% upside to fair value with a price target of $33.33 per share.
CNK vs. S&P 500
-
Over the past 5 trading days, Cinemark Holdings has overperformed the S&P 500 by 2.22% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cinemark Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cinemark Holdings has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Cinemark Holdings reported revenues of $814.3M.
Earnings Growth
-
Cinemark Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cinemark Holdings reported earnings per share of $0.33.
Enterprise value:
4.9B
EV / Invested capital:
--
Price / LTM sales:
1.53x
EV / EBIT:
11.81x
EV / Revenue:
1.62x
PEG ratio (5yr expected):
0.23x
EV / Free cash flow:
15.69x
Price / Operating cash flow:
14.77x
Enterprise value / EBITDA:
8.02x
Gross Profit (TTM):
$2B
Return On Assets:
6.35%
Net Income Margin (TTM):
10.16%
Return On Equity:
70.37%
Return On Invested Capital:
11.13%
Operating Margin:
11.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.5B | $3.1B | $3B | $638.9M | $814.3M | |
| Gross Profit | $1.6B | $2B | $2B | $418.8M | $518.3M | |
| Operating Income | $77M | $371.8M | $362.4M | $25.8M | $96.4M | |
| EBITDA | $151.7M | $603.9M | $616.3M | $76.4M | $153M | |
| Diluted EPS | -$2.25 | $1.23 | $2.03 | -$0.15 | $0.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $892.7M | $874.4M | $863.6M | $1.1B | $1.3B | |
| Total Assets | $5.6B | $5.2B | $4.8B | $4.8B | $5.1B | |
| Current Liabilities | $606.4M | $769.1M | $708.5M | $730.3M | $1.3B | |
| Total Liabilities | $4.8B | $4.9B | $4.7B | $4.5B | $4.5B | |
| Total Equity | $799M | $334.5M | $119.5M | $318.8M | $603.4M | |
| Total Debt | $2.4B | $2.5B | $2.5B | $2.4B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $136M | $444.3M | $466M | $108.5M | $196.4M | |
| Cash From Investing | -$96.3M | -$131.8M | -$146.9M | -$56.9M | -$57.8M | |
| Cash From Financing | -$52.2M | -$125.4M | -$103.1M | -$7.4M | -$8.4M | |
| Free Cash Flow | $25.3M | $294.8M | $315.2M | $48.7M | $135.8M | |
CNK
Sector
Market Cap
$3.7B
$77.9M
Price % of 52-Week High
82.44%
64.54%
Dividend Yield
0.27%
0%
Shareholder Yield
--
3.11%
1-Year Price Total Return
74.5%
-15.49%
Beta (5-Year)
1.912
0.579
Dividend yield:
0.27%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$29.40
200-day SMA
Buy
Level
$28.23
Bollinger Bands (100)
Buy
Level
25.77 - 31.89
Chaikin Money Flow
Buy
Level
14.1M
20-day SMA
Buy
Level
$27.76
Relative Strength Index (RSI14)
Buy
Level
69.81
ADX Line
Buy
Level
42.89
Williams %R
Sell
Level
-5.7862
50-day SMA
Buy
Level
$26.62
MACD (12, 26)
Buy
Level
3.63
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
24.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.343)
Sell
CA Score
(Annual)
Level (-1.7188)
Buy
Beneish M-Score
(Annual)
Level (-2.3367)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.8349)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
Stock Forecast FAQ
In the current month, CNK has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CNK average analyst price target in the past 3 months is $33.33.
-
Where Will Cinemark Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cinemark Holdings share price will rise to $33.33 per share over the next 12 months.
-
What Do Analysts Say About Cinemark Holdings?
Analysts are divided on their view about Cinemark Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cinemark Holdings is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is Cinemark Holdings's Price Target?
The price target for Cinemark Holdings over the next 1-year time period is forecast to be $33.33 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CNK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cinemark Holdings is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CNK?
You can purchase shares of Cinemark Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cinemark Holdings shares.
-
What Is The Cinemark Holdings Share Price Today?
Cinemark Holdings was last trading at $29.87 per share. This represents the most recent stock quote for Cinemark Holdings. Yesterday, Cinemark Holdings closed at $29.91 per share.
-
How To Buy Cinemark Holdings Stock Online?
In order to purchase Cinemark Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
20
EVVTY alert for May 1
Evolution AB [EVVTY] is down 19.01% over the past day.
Sell
47
LANC alert for May 1
Lancaster Colony [LANC] is down 15.56% over the past day.
Sell
36
BHE alert for May 1
Benchmark Electronics [BHE] is down 15.02% over the past day.
